How should findings on antisuicidal effects of lithium be integrated into practical treatment decisions?

European Archives of Psychiatry and Clinical Neuroscience

Volumn 253, Issue 3, 2003, Pages 126-131

  Muller Oerlinghausen B ^a  

^a Drug Commission of the German Medical Association   (Germany)

Author keywords

Affective disorders; Antidepressants; Guidelines; Lithium; Pharmaco economy; Suicide

Indexed keywords

LITHIUM; ANTIDEPRESSANT AGENT;

DRUG EFFICACY; GERMANY; HUMAN; MEDICAL DECISION MAKING; MOOD DISORDER; MORTALITY; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SUICIDAL BEHAVIOR; ALGORITHM; ECONOMICS; HEALTH CARE COST; RISK; SUICIDE;

ALGORITHMS; ANTIDEPRESSIVE AGENTS; HEALTH CARE COSTS; HUMANS; LITHIUM; MOOD DISORDERS; MORTALITY; ODDS RATIO; SUICIDE;

EID: 0042831063     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00406-003-0428-3     Document Type: Review

References (50)

1. Ahrens B, Müller-Oerlinghausen B, Schou M, Wolf T, Alda M, Grof E, Grof P, Lenz G, Simhandl C, Thau K, Wolf R, Möller HJ (1995) Excess cardiovascular and suicide mortality of affective disorders may be reduced by lithium-prophylaxis. J Aff Disord 33:67-75
2. Ahrens B, Müller-Oerlinghausen B (1997) Die antisuizidale und mortalitätssenkende Wirkung von Lithium. In: Müller-Oerlinghausen B, Greil W, Berghöfer A (eds) Die Lithiumtherapie. Springer-Verlag Berlin Heidelberg New York, pp 262-277
3. Ahrens B, Müller-Oerlinghausen B (2001) Does lithium exert an independent antisuicidal effect. Pharmacopsychiatry 34:132-136
4. Angst J, Sellaro R, Angst F (1998) Long-term outcome and mortality of treated vs. untreated bipolar and depressed patients: a preliminary report. Int J Psychiatr Clin Pract 2:115-119
5. APA (2000) Practice guidelines for the treatment of patients with major depressive disorder (revision). Am J Psychiatry 157 (4, suppl):1-45
6. Baldessarini RJ, Tondo L, Hennen J (2001) Reduced suicide risk during long-term treatment with lithium. Ann NY Acad Sci 932:24-43
7. Barraclough B (1972) Suicide prevention, recurrent affective disorder and lithium. Br J Psychiatry 121:391-392
8. Berghöfer A, Bauer M, Müller-Oerlinghausen B (2002) Antisuicidal effect of lithium as a criterion for the selection of appropriate long-term medication in bipolar patients. In: Kaschka WP (ed) Perspectives in Affective Disorders. Advanced Biological Psychiatry. Karger Basel. Vol. 21:1-9
9. Bottlender R, Jager M, Strauss A, Möller HJ (2000) Suicidality in bipolar compared to unipolar depressed inpatients. Eur Arch Psychiatry Clin Neurosci 250:257-261
10. Burgess S, Geddes J, Hawton K, Townsend E, Jamison K, Goodwin G (2001) Lithium for maintenance treatment of mood disorders (Cochrane Review). In: The Cochrane Library, Issue 3. Update Software, Oxford
11. Coppen A (1994) Depression as a lethal disease: prevention strategies. J Clin Psychiatry 55 (4, suppl):37-45
12. Coppen A, Standish-Barry H, Bailey J, Houston G, Silcocks P, Hermon C (1991) Does lithium reduce the mortality of recurrent mood disorders? J Aff Disord 23:1-7
13. Felber W, Kyber A (1994) Suizide und Parasuizide während und außerhalb einer Lithiumprophylaxe. In: Müller-Oerlinghausen B, Berghöfer A (eds) Ziele und Ergebnisse der medikamentösen Prophylaxe affektiver Psychosen. Georg Thieme Verlag Stuttgart New York, pp 53-59
14. Goodwin FK (1999) Anticonvulsant therapy and suicide in affective disorders. J Clin Psychiatry 60 (2, suppl):89-93
15. Goodwin FK, Jamison KR (1990) Manic-depressive illness. New York: Oxford University Press
16. Goodwin FK, Jamison KR (eds) (1983) Manic depressive illness. Oxford University Press, Oxford
17. Greil W, Ludwig-Mayerhofer W, Erazo N, Schöchlin C, Schmidt S, Engel RR, Czernik A, Giedke H, Müller-Oerlinghausen B, Osterheider M, Rudolf GAE, Sauer H, Tegeler J, Wetterling T (1997) Lithium versus carbamazepine in the maintenance treatment of bipolar disorders - a randomised study. J Aff Diord 43:151-161
18. Guze SB, Robins E (1970) Suicide in primary affective disorders. Br J Psychiatry 117:437-438
19. Hagnell O, Lanke J, Rorsman B (1981) Suicide rates in the Lundby study: mental illness as a risk factor for suicide. Neuropsychobiology 7:248-253
20. Harris EC, Barraclough B (1998) Excess mortality of mental disorder. Br J Psychiatry 173:11-53
21. Isacsson G (2000) Frequency of suicides reduced with 25 percent: probably by the increased use of antidepressive agents. Lakartidningen 97:1644-1650
22. Isacsson G, Holmgren P, Druid H, Bergman U (1997) The utilization of antidepressants - a key issue in the prevention of suicide. An analysis of 5, 281 suicides in Sweden 1992-94. Acta Psychiatr Scand 96:94-100
23. Kallner G, Lindelius R, Petterson U, Stockman O, Tham A (2000) Mortality in 497 patients with affective disorders attending a lithium clinic after having left it. Pharmacopsychiatry 33:8-13
24. Kay DWK, Petterson U (1977) Mortality. In: Petterson U (ed) Manic depressive illness: a clinical, social and genetic study. Acta Psychiatr Scand (suppl 269):55-60
25. Lehmann K, Ahrens B, Müller-Oerlinghausen B (1997) Pharmakoökonomie der Lithiumprophylaxe. In: Müller-Oerlinghausen B, Greil W, Berghöfer A (eds) Die Lithiumtherapie. Springer-Verlag Berlin Heidelberg New York, pp 262-277
26. Lenz G, Ahrens B, Denk E, Müller-Oerlinghausen B, Schratzberger-Topitz A, Simhandl C, Wancata J (1994) Mortalität nach Ausscheiden aus der Lithiumambulanz. In: Müller-Oerlinghausen B, Berghöfer A (eds) Ziele und Ergebnisse der medikamentösen Prophylaxe affektiver Psychosen. Georg Thieme Verlag Stuttgart New York, pp 49-52
27. Lester D (1993) Suicidal behavior in bipolar and unipolar affective disorders: a meta-analysis. J Aff Disord 27:117-121
28. Lundquist G (1945) Prognosis and cause of manic depressive psychosis. Acta Psychiat et Neurol Scand 35:1-96
29. Meltzer HY (1999) Suicide and schizophrenia: clozapine and the InterSePT study. International Clozaril/Leponex Suicide Prevention Trial. J Clin Psychiatry 60 (12, suppl):47-50
30. Motto I (1965) Suicide attempts: a longitudinal view. Arch Gen Psychiatry 13:516-520
31. Müller-Oerlinghausen B, Ahrens B, Grof E, Grof P, Lenz G, Schou M, Simhandl C, Thau K, Volk J, Wolf R, Wolf T (1992a) The effect of long-term lithium treatment on the mortality of patients with manic-depressive and schizo-affective illness. Acta Psychiatr Scand 86:218-222
32. Müller-Oerlinghausen B, Müser-Causemann B, Volk J (1992b) Suicides and parasuicides in a high-risk patient group on and off lithium long-term medication. J Aff Disord 25:261-270
33. Müller-Oerlinghausen B, Wolf T, Ahrens B, Schou M, Grof E, Grof P, Lenz G, Simhandl C, Thau K, Wolf R (1994) Mortality during initial and during later lithium treatment: a collaborative study by IGSLI. Acta Psychiatr Scand 90:295-297
34. Müller-Oerlinghausen B, Berghöfer A (1999) Antidepressants and suicidal risk. J Clin Psychiatry 60 (2, suppl):94-99
35. Müller-Oerlinghausen B, Lorenzen A, Lohse MJ (2002) Psychopharmaka. In: Schwabe U, Paffrath D (eds) Arzneiverordnungs-Report 2002. Springer-Verlag Berlin Heidelberg New York,(2003)
36. Newman S, Bland R (1991) Suicide risk varies by subtype of affective disorder. Acta Psychiatr Scand 83:420-426
37. Nilsson A (1995) Mortality in recurrent mood disorders during periods on and off lithium. A complete population study in 362 patients. Pharmacopsychiatry 28:8-13
38. Norton B, Whalley LJ (1984) Mortality of a lithium-treated population. Br J Psychiatry 145:277-282
39. Ösby U, Brandt L, Correia N, Ekbom A, Sparen P (2001) Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry 58:844-850
40. Schou M (1998) The effect of prophylactic lithium treatment on mortality and suicidal behavior: a review for clinicians. J Aff Dis 50:253-259
41. Solomon DA, Keller MB, Leon AC, Müller TI, Lavori PW, Shea T, Coryell W, Warshaw M, Turvey C, Maser JD, Endicott J (2000) Multiple recurrences of major depressive disorder. Am J Psychiatry 157:229-233
42. Thies-Flechtner K, Müller-Oerlinghausen B, Seibert W, Walther A,Greil W (1996) Effect of prophylactic treatment on suicide risk in patients with major affective disorders. Data from a randomized prospective trial. Pharmacopsychiatry 29:103-107
43. Tondo L, Baldessarini RJ, Floris G, et al. (1996) Lithium maintenance treatment reduces risk of suicidal behavior in bipolar disorder patients. In: Gallicchio VS, Birch NJ (eds) Lithium: Biochemical and clinical advances. Cheshire, Conn: Weidner Publishing Group, pp 161-171
44. Tondo L, Jamison KR, Baldessarini RJ (1997) Effect of lithium maintenance on suicidal behavior in major mood disorders. In: Stoff DM, Mann JJ (eds) The neurobiology of suicide: From the bench to the clinic. Ann NY Acad Sci 836:339-351
45. Tsuang MT, Woolson RF (1978) Excess mortality in schizophrenia and affective disorders. Do suicides and accidental deaths solely account for this excess? Arch Gen Psychiatry 35:1181-1185
46. Tuckman J, Youngman W (1963) Identifying suicide with groups among attempted suicide. Public Health Rep 78:763-766
47. Vestergaard P, Aagaard J (1991) Five-year mortality in lithium-treated manic-depressive patients. J Aff Disord 21:33-38
48. Weeke A (1979) Causes of death in manic depressives. In: Schou M, Strömgren E (eds) Origin, prevention and treatment of affective disorders. Academic Press, London, pp 289-299
49. Weissman MM, Bruce ML, Leaf PJ, et al. (1991) Affective disorders. In: Robins LN, Regier DA (eds) Psychiatric Disorders in America. The Free Press, New York
50. Wolf T, Müller-Oerlinghausen B, Ahrens B, Grof P, Schou M, Felber W, Grof E, Lenz G, Nilsson A, Simhandl C, Thau K, Vestergaard P, Wolf R (1996) How to interpret findings on mortality of long-term lithium treated manic-depressive patients? Critique of different methodological approaches. J Aff Disord 39:127-132